{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:14:44Z","timestamp":1762917284278},"reference-count":39,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.prostaglandins.2010.08.001","type":"journal-article","created":{"date-parts":[[2010,8,11]],"date-time":"2010-08-11T05:17:24Z","timestamp":1281503844000},"page":"113-119","source":"Crossref","is-referenced-by-count":17,"title":["Inhibitive effect of celecoxib on the adhesion and invasion of human tongue squamous carcinoma cells to extracellular matrix via down regulation of MMP-2 expression"],"prefix":"10.1016","volume":"93","author":[{"given":"Wei Zhong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu Ju","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0010","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10555-007-9082-y","article-title":"Metastasis of squamous cell carcinoma of the oral tongue","volume":"26","author":"Sano","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1152\/physrev.1993.73.1.161","article-title":"Biology and biochemistry of proteinases in tumor invasion","volume":"73","author":"Mignatti","year":"1993","journal-title":"Physiol Rev"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0020","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev.cb.09.110193.002545","article-title":"Tumor cell interactions with the extracellular matrix during invasion and metastasis","volume":"9","author":"Stetler-Stevenson","year":"1993","journal-title":"Annu Rev Cell Biol"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0025","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5483\/BMBRep.2003.36.1.128","article-title":"Roles of matrix metalloproteinases in tumor metastasis and angiogenesis","volume":"36","author":"Yoon","year":"2003","journal-title":"J Biochem Mol Biol"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/bies.950140705","article-title":"The matrix-degrading metalloproteinases","volume":"14","author":"Matrisian","year":"1992","journal-title":"Bioessays"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","article-title":"Matrix metalloproteinases and tumor metastasis","volume":"25","author":"Deryugina","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ajcp\/99.1.18","article-title":"Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study","volume":"99","author":"Kusukawa","year":"1993","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0045","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/89.17.1260","article-title":"Changing views of the role of matrix metalloproteinases in metastasis","volume":"89","author":"Chambers","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0050","first-page":"151","article-title":"Activation mechanisms of matrix metalloproteinases","volume":"378","author":"Nagase","year":"1997","journal-title":"Biol Chem"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/370061a0","article-title":"matrix metalloproteinase expressed on the surface of invasive tumour cells","volume":"370","author":"Sato","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0060","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1158\/1078-0432.CCR-0864-02","article-title":"Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis","volume":"10","author":"Katayama","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jcp.1041560204","article-title":"Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro","volume":"156","author":"Schnaper","year":"1993","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0070","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","article-title":"Cyclooxygenase in biology and disease","volume":"2","author":"Dubois","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0075","first-page":"1306","article-title":"Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors","volume":"60","author":"Masferrer","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0080","first-page":"135","article-title":"Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer","volume":"6","author":"Uefuji","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.gastro.2007.09.035","article-title":"Aspirin dose and duration of use and risk of colorectal cancer in men","volume":"134","author":"Chan","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0090","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/ijc.22546","article-title":"Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study","volume":"120","author":"Genkinger","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0095","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/jnci\/dji173","article-title":"A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence","volume":"97","author":"Jacobs","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0100","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.cgh.2007.05.022","article-title":"Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers","volume":"5","author":"Fortuny","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0105","first-page":"1451","article-title":"Increased expression of cyclooxygenase-2 protein in 4-nitroquinoline-1-oxide-induced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, nimesulide","volume":"61","author":"Shiotani","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.critrevonc.2006.07.001","article-title":"Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic","volume":"61","author":"de Groot","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0115","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s004320000225","article-title":"Cyclooxygenase-2: a novel target for cancer chemotherapy?","volume":"127","author":"Dempke","year":"2001","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.critrevonc.2006.01.003","article-title":"Cyclooxygenase-2 as a target for anticancer drug development","volume":"59","author":"M\u00e9ric","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0125","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","article-title":"The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis","volume":"342","author":"Steinbach","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0130","first-page":"5599","article-title":"Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats","volume":"60","author":"Grubbs","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0135","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1158\/1078-0432.CCR-04-1684","article-title":"Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib","volume":"11","author":"Li","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0140","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1600-0714.2004.00254.x","article-title":"Increased expression of cyclooxygenase (COX)-2 in DMBA-induced hamster cheek pouch carcinogenesis and chemopreventive effect of a selective COX-2 inhibitor celecoxib","volume":"33","author":"Nishimura","year":"2004","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0145","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.oraloncology.2003.09.005","article-title":"Overexpression of cyclooxygenase-2 is associated with radioresistance in oral squamous cell carcinoma","volume":"40","author":"Terakado","year":"2004","journal-title":"Oral Oncol"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0150","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s10350-007-9120-4","article-title":"Cyclooxygenase-2 inhibition prevents migration of colorectal cancer cells to extracellular matrix by down-regulation of matrix metalloproteinase-2 expression","volume":"51","author":"Leung","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0155","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2407-6-181","article-title":"Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression","volume":"6","author":"Larkins","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10585-009-9241-3","article-title":"Inhibition of cyclooxygenase-2 suppresses the invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 production and activation","volume":"26","author":"Kurihara","year":"2009","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1196\/annals.1397.014","article-title":"The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma","volume":"1095","author":"Kwak","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0170","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.bcp.2003.12.014","article-title":"Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells","volume":"67","author":"Maier","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0175","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1096\/fj.04-3274fje","article-title":"Targeting the beta-catenin\/APC pathway: a novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cells","volume":"19","author":"Maier","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0180","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.canlet.2006.11.032","article-title":"Celecoxib induces apoptosis in COX-2 deficient human gastric cancer cells through Akt\/GSK3beta\/NAG-1 pathway","volume":"251","author":"Pang","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0185","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1111\/j.1582-4934.2008.00580.x","article-title":"Cyclooxygenase-2\/carbonic anhydrase-IX up-regulation promotes invasive potential and hypoxia survival in colorectal cancer cells","volume":"13","author":"Sansone","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cdp.2003.12.005","article-title":"Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention","volume":"28","author":"Kismet","year":"2004","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.prostaglandins.2010.08.001_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0090-6980(95)00154-9","article-title":"Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells","volume":"51","author":"Reich","year":"1996","journal-title":"Prostaglandins"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882310000808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882310000808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T12:00:25Z","timestamp":1559390425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882310000808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":39,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S1098882310000808"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2010.08.001","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}